Medical Technology Investment Banking

FOCUS’s Medical Technology Investment Banking team advises founders, executives, and shareholders through complex transactions at critical inflection points. Our bankers combine rigorous financial modeling with thoughtful positioning and a structured, confidential marketing process designed to clearly articulate value and generate competitive interest from qualified private equity and strategic buyers. The result is a disciplined approach that maximizes outcomes while helping medical technology leaders identify partners aligned with their growth strategy and long-term vision.

Medical technology is entering a new phase of growth as innovation accelerates across diagnostics, therapeutics, and care delivery. Private equity investment in the sector continues to surge as firms target AI-enabled diagnostic tools, connected wearables, advanced therapeutic devices, biopharmaceutical production technologies, and research tools that support a broader shift toward home-based and decentralized healthcare. These technologies are reshaping how care is delivered, monitored, and scaled which is creating significant opportunity for differentiated platforms.

Investors are particularly focused on medical technology companies that enable efficiency, improve clinical decision-making, and integrate seamlessly into evolving healthcare ecosystems. Businesses that demonstrate strong intellectual property, regulatory progress, scalable manufacturing or software models, and clear pathways to commercialization are commanding heightened interest from both financial sponsors and strategic acquirers seeking exposure to long-term healthcare innovation.